Back

Notification report


Full notification file


General information

Notification Number
B/HU/21/01

Member State to which the notification was sent
Hungary

Date of acknowledgement from the Member State Competent Authority
20/04/2021

Title of the Project
Evaluation of Field Safety and Efficacy by Serology in Broilers in Hungary after Vaccination via the Subcutaneous Route with a Herpes Virus of Turkey Vaccine Carrying a VP2 Gene of Infectious
Bursal Disease (Poulvac Procerta HVTIBD)


Proposed period of release:
01/05/2021 to 31/05/2022

Name of the Institute(s) or Company(ies)
Klifovet AG, Geyerspergerstra├če 27
80689 Munich
Germany;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Spain; Italy; Hungary;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The GMO consists of a live cell-associated Herpes of Turkey (HVT) strain FC-126 that has been genetically modified by inserting the VP2 gene of infectious bursal disease virus (IBDV) into the HVT strain FC-126 genome.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HVTMardivirusMeleagrid herpes virus 1-FC 126 strain-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known